Skip to main content
Quest Diagnostics

Remote Specimen Collection & At Home Testing Strategies: Where do we go from here?

31st International Presicion Med TRI-CON, 2024

San Diego, CA, March 26-27, 2024

Oral presentation: Remote Specimen Collection & At Home Testing Strategies: Where do we go from here?

Authors: Marlowe E

Specialty: Infectious disease

Related content

On-Demand Webinar
Quality Considerations for Mobile Blood Draws and Specimen Collections: Supporting Decentralized Studies and Trials
Audio Podcast
Alternative Specimen Collection Options
Publication
Validation of a Mail-In Delayed Semen Analysis Protocol Developed for Home Collection
Publication
Performance of Unobserved Self-collected Nasal Swabs for Detection of SARS-CoV-2 by RT-PCR Utilizing a Remote Specimen Collection Strategy.
Publication
Evolution of Specimen Self-Collection in the COVID-19 Era: Implications for Population Health Management of Infectious Disease
Conference Presentation
Issues and Challenges for Clinical Studies for Home Collection Devices

Our company

Quest® is the brand name used for services offered by Quest Diagnostics Incorporated and its affiliated companies. Quest Diagnostics Incorporated and certain affiliates are CLIA-certified laboratories that provide HIPAA-covered services.  Other affiliates operated under the Quest® brand, such as Quest Consumer Inc., do not provide HIPAA-covered services. 

 

Quest®, Quest Diagnostics®, any associated logos, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks—® and ™—are the property of their respective owners. © 2025 Quest Diagnostics Incorporated. All rights reserved. Image content features models and is intended for illustrative purposes only.